Virology: From contagium fluidum to virome

Fields Virology: Sixth Edition

Volumn 1, Issue , 2013, Pages

  Enquist, Lynn W ^a   Racaniello, Vincent R ^b  

^a PRINCETON UNIVERSITY   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924624857     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (212)

1. Alberts BM, Bedinger BP, Formosa T. Studies on DNA replication in the bacteriophage T4 in vitro systems. Cold Spring Harbor Symp Quant Biol 1982;47:655-668.
2. Angly F, Felts B, Breitbart M, et al. The marine viromes of four oceanic regions. PLoS Biol 2006;4:e368.
3. Arvin A, Greenberg HB. New viral vaccines. Virology 2006;344:240-249.
4. Astrachan L, Volkin E. Properties of ribonucleic acid turnover in T2-infected Escherichia coli. Biochim Biophys Acta 1958;29:536-544.
5. Avery OT, Macleod CM, McCarty M. Studies on the Chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 1044;79:137-158.
6. Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 1970;226:1209-1211.
7. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-871.
8. Bawden FC, Pirie NW. The isolation and some properties of liquid crystalline substances from solanaceous plants infected with three strains of tobacco mosaic virus. Proc R Soc Med 1937;123:274-320.
9. Bawden FC, Pirie NW, Bernal JD, et al. Liquid crystalline substances from virus infected plants. Nature 1939;138:1051-1052.
10. Beijerinck M. Concerning a contagium vivum fluidum as a cause of the spot-disease of tobacco leaves. Verh Akad Wetensch, Amsterdam, II 1898;6:3-21.
11. Bely V, Levine A, Skalka A. Sequences from ancestral single-stranded DNA viruses in vertebrate genomes: the parvoviridae and Circoviridae are more than 40-50 million years old. J Virol 2010;84:12458-12464.
12. Bely V, Levine A, Skalka A. Unexpected inheritance: multiple integrations of ancient bornavirus and ebola/marburgvirus sequences in vertebrate genomes. PLoS Pathogens 2010;6:e1001030.
13. Benzer S. Fine Structure of a Genetic Region in Bacteriophage. Proc Natl Acad Sci U S A 1955;41:344-354.
14. Benzer S, Champe SP. Ambivalent rII Mutants of Phage T4. Proc Natl Acad Sci U S A 1961;47:1025-1038.
15. Berget SM, Moore C, Sharp PA. Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci U S A 1977;74:3171-3175.
16. Bernal JD, Fankuchen I. X-ray and crystallographic studies of plant virus preparations. J Gen Physiol 1941;25:147-165.
17. Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 2004;5:1109-1115.
18. Biggs PM, Payne LN, Milne BS, et al. Field trials with an attenuated cell associated vaccine for Marek's disease. Vet Rec 1970;87:704-709.
19. Biurungi G, Chen S, Loy B, et al. Metabolomics approach for investigation of effects of dengue fever infection using the EA.hy926 cell line. J Proteome Res 2010;9:6523-6534.
20. Blumberg BS, Gerstley BJ, Hungerford DA, et al. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med 1967;66:924-931.
21. Bohmann D, Bos TJ, Admon A, et al. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987;238:1386-1392.
22. Bordet J. Concerning the theories of the so-called "bacteriophage". Br Med J 1922;2:296.
23. Buonaguro L, Pulendran B. Immunogenomics and systems biology of vaccines. Immunol Rev 2011;1:197-208.
24. Burkitt D. A children's cancer dependent on climatic factors. Nature 1962;194:232-234.
25. Butler PJ, Klug A. Assembly of the particle of tobacco mosaic virus from RNA and disks of protein. Nat New Biol 1971;229:47-50.
26. Cairns J, ed. The Autoradiography. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1966.
27. Campbell AM. Episomes. Adv Genet 1962;11:101-145.
28. Chakrabarti A, Jha B, Silverman R. New insights into the role of Rnase L in innate immunity. J Interferon Cytokine Res 2011;31:49-57.
29. Chiu Y-L, Greene W. APOBEC3G: an intracellular centurion. Philos Trans R Soc Lond B Biol Sci 2009;364:689-703.
30. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
31. Chow LT, Gelinas RE, Broker TR, et al. An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. Cell 1977;12:1-8.
32. Cohen SS. Virus-induced Enzymes. New York: Columbia University Press; 1968.
33. Crick FH, Watson JD. Structure of small viruses. Nature 1956;177:473-475.
34. d'Herelle F. The Bacteriophage and Its Behavior. Baltimore: Williams & Wilkins; 1926.
35. d'Herelle F. Le microbe bactériophage, agent d'immunité dans la peste et le barbone. C R Hebd Seances Acad Sci Paris 1921;72:99.
36. d'Herelle F. Sur un microbe invisible antagoniste des bacilles dysentériques. C R Hebd Seances Acad Sci Paris 1917;1:72-99.
37. Danna K, Nathans D. Specific cleavage of simian virus 40 DNA by restriction endonuclease of Hemophilus influenzae. Proc Natl Acad Sci U S A 1971;68:2913-2917.
38. Danna KJ, Sack GH Jr, Nathans D. Studies of simian virus 40 DNA. VII. A cleavage map of the SV40 genome. J Mol Biol 1973;78:363-376.
39. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
40. DeCaprio JA, Ludlow JW, Figge J, et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988;54:275-283.
41. Ding S-W, Voinet O. Antiviral immunity directed by small RNAs. Cell 2007;130:413-426.
42. Dulbecco R, Vogt M. Evidence for a Ring Structure of Polyoma Virus DNA. Proc Natl Acad Sci U S A 1963;50:236-243.
43. Dulbecco R, Vogt M. Some problems of animal virology as studied by the plaque technique. Cold Spring Harb Symp Quant Biol 1953;18:273-279.
44. Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 1983;35:79-87.
45. Dyson N, Howley PM, Munger K, et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-937.
46. Eagle H. The specific amino acid requirements of a human carcinoma cell (Stain HeLa) in tissue culture. J Exp Med 1955;102:37-48.
47. Edgar RS, Wood WB. Morphogenesis of bacteriophage T4 in extracts of mutant-infected cells. Proc Natl Acad Sci U S A 1966;55:498-505.
48. Edwards RA, Rohwer F. Viral metagenomics. Nature reviews. Microbiology 2005;3:504-510.
49. Eidson CS, Kleven SH, Anderson DP. Vaccination Against Marek's Disease. Lyon: Oncogenesis and Herpesvirus; 1972.
50. Ellermann V, Bang O. Experimentelle Leukamie bei Huhnern. Zentralbl Bakteriol Alet I 1908;46:595-597.
51. Ellis EL, ed. Bacteriophage: One-step Growth. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1966.
52. Ellis EL, Delbruck M. The Growth of Bacteriophage. J Gen Physiol 1939;22:365-384.
53. Emerman M, Malik H. Paleovirology- modern consequences of ancient viruses. PLoS Biology 2010;8:e1000301.
54. Enders JF, Weller TH, Robbins FC. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 1949;109:85-87.
55. Enquist L. Virology in the 21st Century. J Virol 2009;83:5296-5308.
56. Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 1964;1:702-703.
57. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100.
58. Fenner F, Nakano JJ. Poxviridae: The poxviruses. In: Lennette EH, Halonen P, Murphy FA, ed. The Laboratory Diagnosis of Infectious Diseases: Principles and Practice, Viral, Rickettsial, and Chlamydial Diseases, vol. 2. New York: Springer-Verlag; 1988.
59. Fitzgerald M, Shenk T. The sequence 5'-AAUAAA-3'forms parts of the recognition site for polyadenylation of late SV40 mRNAs. Cell 1981;24:251-260.
60. Flaks JG, Cohen SS. Virus-induced acquisition of metabolic function. I. Enzymatic formation of 5-hydroxymethyldeoxycytidylate. J Biol Chem 1959;234:1501-1506.
61. Flint SJ, Enquist LW, Racaniello VR, et al. Principles of Virology. Washington, DC: ASM Press; 2009.
62. Fowlkes DM, Shenk T. Transcriptional control regions of the adenovirus VAI RNA gene. Cell 1980;22:405-413.
63. Fraenkel-Conrat H, Singer B. The chemical basis for the mutagenicity of hydroxylamine and methoxyamine. Biochim Biophys Acta 1972;262:264-268.
64. Fraenkel-Conrat H, Singer B, Williams RC. Infectivity of viral nucleic acid. Biochim Biophys Acta 1957;25:87-96.
65. Freeman VJ. Studies on the virulence of bacteriophage-infected strains of Corynebacterium diphtheriae. J Bacteriol 1951;61:675-688.
66. Furth J, Strumia M. Studies on Transmissible Lymphoid Leucemia of Mice. J Exp Med 1931;53:715-731.
67. Furuichi Y, Morgan M, Muthukrishnan S. Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp. Proc Natl Acad Sci U S A 1975;72:362-366.
68. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500-503.
69. Gaynor RB, Hillman D, Berk AJ. Adenovirus early region 1A protein activates transcription of a nonviral gene introduced into mammalian cells by infection or transfection. Proc Natl Acad Sci U S A 1984;81:1193-1197.
70. Germond JE, Hirt B, Oudet P, et al. Folding of the DNA double helix in chromatin-like structures from simian virus 40. Proc Natl Acad Sci U S A 1975;72:1843-1847.
71. Gey GO, Coffman WD, Kubicek MT. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952;12:264-265.
72. Gierer A, Schramm G. Infectivity of ribonucleic acid from tobacco mosaic virus. Nature 1956;177:702-703.
73. Goeddel DV, Shepard HM, Yelverton E, et al. Synthesis of human fibroblast interferon by E. coli. Nucleic Acids Res 1980;8:4057-4074.
74. Goff SP, Berg P. Construction of hybrid viruses containing SV40 and lambda phage DNA segments and their propagation in cultured monkey cells. Cell 1976;9:695-705.
75. Gribskov M, Burgess RR. Sigma factors from E. coli, B. subtilis, phage SP01, and phage T4 are homologous proteins. Nucleic Acids Res 1986;14:6745-6763.
76. Gruss P, Dhar R, Khoury G. Simian virus 40 tandem repeated sequences as an element of the early promoter. Proc Natl Acad Sci U S A 1981;78:943-947.
77. Hayward WS, Neel BG, Astrin SM. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 1981;290:475-480.
78. Hearing P, Shenk T. Sequence-independent autoregulation of the adenovirus type 5 E1A transcription unit. Mol Cell Biol 1985;5:3214-3221.
79. Henderson DA. Principles and lessons from the smallpox eradication programme. Bull World Health Organ 1987;65:535-546.
80. Henderson DA. Smallpox Virus Destruction and the Implications of a New Vaccine. Biosecur Bioterror 2011;9(2)163-168.
81. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A 1968;59:94-101.
82. Hershey AD. The Bacteriophage Lambda. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1971.
83. Hershey AD, Chase M. Independent functions of viral protein and nucleic acid in growth of bacteriophage. J Gen Physiol 1952;36:39-56.
84. Hilleman MR. Historical and contemporary perspectives in vaccine developments: from the vantage of cancer. Prog Med Virol 1992;39:1-18.
85. Ho D, Bieniasz P. HIV at 25. Cell 2008;454:236-240.
86. Hoh J, Jin S, Parrado T, et al. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci U S A 2002;99:8467-8472.
87. Holmes E. The evolutionary genetics of emerging viruses. Ann Rev Ecol Evol Syst 2009;40:353-372.
88. Holmes FA. Local lesions in tobacco mosaic. Bot Gaz 1929;87:39-55.
89. Hughes SS. The Virus: A History of the Concept. London: Heinemann Education Books; 1977.
90. Hui D, Chan P. Severe acute respiratory syndrome and coronavirus. Infect Dis Clin North Am 2010;24:619-638.
91. Inglis T. Principia aetiologica: taking causality beyond Koch's postulates. J Med Micro 2007;56:1419-1422.
92. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957;147:258-267.
93. Isaacs A, Lindenmann J, Valentine RC. Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci 1957;147:268-273.
94. Ivanofsky D. Concerning the mosaic disease of the tobacco plant. St. Petersburg Acad Imp Sci Bull 1892;35:67-70.
95. Ivanofsky D. On the mosaic disease of tobacco. Zeitschrift fur Pfanzenkrankheit 1903;13:1-41.
96. Jackson DA, Symons RH, Berg P. Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli. Proc Natl Acad Sci U S A 1972;69:2904-2909.
97. Jacob F, Wollman E. Etude génétique d'un bactériophage tempéré d'Escherichia coli. I. Le système génétique du bactériophage l. Ann Inst Pasteur 1954;87:653-673.
98. Jacob F, Wollman E. Sexuality and the Genetics of Bacteria. New York: Academic Press; 1961.
99. Jang SK, Davies MV, Kaufman RJ, et al. Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol 1989;63:1651-1660.
100. Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nature reviews. Microbiology 2005;3:281-294.
101. Jensen JH. Isolation of yellow-mosaic virus from plants infected with tobacco mosaic. Phytopathology 1933;23:964-974.
102. Kates J, Beeson J. Ribonucleic acid synthesis in vaccinia virus. II. Synthesis of polyriboadenylic acid. J Mol Biol 1970;50:19-33.
103. Kates JR, McAuslan BR. Poxvirus DNA-dependent RNA polymerase. Proc Natl Acad Sci U S A 1967;58:134-141.
104. Kausche G. Die Sichtbarmachung von PF lanzlichem Virus in Ubermikroskop. Naturwissenschaften 1939;27:292-299.
105. Kausche G, Ankuch PF, Ruska H. Die Sichtbarmachung von PF lanzlichem Virus in Ubermikroskop. Naturwissenschaften 1939;27:292-299.
106. Keesing F, Belden L, Daszak P, et al. Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature 2010;468:647-652.
107. Kinross J, Darzi A, Nicholson J. Gut microbiome-host interactions in health and disease. Genome Med 2011;3:14.
108. Kitajewski J, Schneider RJ, Safer B, et al. An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines. Mol Cell Biol 1986;6:4493-4498.
109. Kornberg A. Biologic synthesis of deoxyribonucleic acid. Science 1960;131:1503-1508.
110. Kotin RM, Siniscalco M, Samulski RJ, et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A 1990;87:2211-2215.
111. Krugman S, Giles JP, Hammond J. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967;200:365-373.
112. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
113. Laemmli UK, Cheng SM, Adolph KW, et al. Metaphase chromosome structure: the role of nonhistone proteins. Cold Spring Harb Symp Quant Biol 1978;42(Pt 1):351-360.
114. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
115. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979;278:261-263.
116. Lee W, Haslinger A, Karin M, et al. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 1987;325:368-372.
117. Levine AJ. The origins of the small DNA tumor viruses. Adv Cancer Res 1994;65:141-168.
118. Levine AJ. The tumor suppressor genes. Annu Rev Biochem 1993;62:623-651.
119. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-456.
120. Linzer DI, Levine AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979;17:43-52.
121. Lipkin I. Pathogen discovery. PLoS Pathogens 2008;4:31000002.
122. Loeffler F, Frosch P. Zentralbl Bakteriol 1. Orig 1898;28:371.
123. Long C, Turner-Shelef K, Relman D. Building a better virus trap. Trends Biotechnol 2007;12:535-538.
124. Luria SE. General Virology. New York: Wiley; 1953.
125. Luria SE. Mutations of Bacterial Viruses Affecting Their Host Range. Genetics 1945;30:84-99.
126. Luria SE, Anderson TF. The Identification and Characterization of Bacteriophages with the Electron Microscope. Proc Natl Acad Sci U S A 1942;28:127-1301.
127. Luria SE, Darnell JE. General Virology. New York: J. Wiley and Sons; 1967.
128. Lwoff A, ed. The Prophage and I. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1961.
129. Lwoff A, Siminovitch L, Kjeldgaard N. Induction de la lyse bactériophagique de la totalité d'une population microbienne lysogène. C R Hebd Seances Acad Sci Paris 1950;231:190-191.
130. Mayer A. On the mosaic disease of tobacco: prelminary communication. Tijdschr Landbouwk 1882;2:359-364.
131. Mayer A. On the mosaic disease of tobacco. Landwn VerSStnen 1886;32:451-467.
132. McKinney HH. Factors affecting the properties of a virus. Phytopathology 1926;16:753-758.
133. McKinney HH. Mosaic diseases in the Canary Islands. J Agric Res 1929;39:557-578.
134. Monod J, Wollman E. L'inhibition de la croissance et de l'adaption enzymatique chez les bactéries infectées par le bactériophage. Ann Inst Pasteur 1947;73:937-957.
135. Moore P, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumor virology. Nat Rev Cancer 2010;12:878-889.
136. Morrow JF, Berg P. Cleavage of Simian virus 40 DNA at a unique site by a bacterial restriction enzyme. Proc Natl Acad Sci U S A 1972;69:3365-3369.
137. Morse ML, Lederberg EM, Lederberg J. Transduction in Escherichia Coli K-12. Genetics 1956;41:142-156.
138. Mulder C, Delius H. Specificity of the break produced by restricting endonuclease R1 in Simian virus 40 DNA, as revealed by partial denaturation mapping. Proc Natl Acad Sci U S A 1972;69:3215-3219.
139. Munger J, Bennett B, Parkikh A, et al. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 2008;10:1179-1186.
140. Murray K, Mertens E, Despres P. West Nile virus and its emergence in the United States of America. Vet Res 2010;41:67.
141. Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010;172:1213-1229.
142. Negri A. Beitrag zum Stadium der Aetiologie der Tollwuth. Z Hyg Infektkrankh 1903;43:507-528.
143. Palacio G, Briese T, Lipkin I. Microbe hunting in laboratory animal research. ILAR J 2010;51:245-254.
144. Parrish C, Kawaoka Y. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol 2005;59:553-586.
145. Pasteur L. Méthode pour prévenir la rage apres morsure. CR Acad Sci 1885;101:765-772.
146. Pelletier J, Sonenberg N. Internal binding of eucaryotic ribosomes on poliovirus RNA: translation in HeLa cell extracts. J Virol 1989;63:441-444.
147. Pilder S, Moore M, Logan J, et al. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol 1986;6:470-476.
148. Plotkin JB, Dushoff J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci U S A 2003;100:7152-7157.
149. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-7419.
150. Ptashne M. A Genetic Switch, Gene Control and Phage Lambda. Palo Alto, CA: Blackwell Science; 1987.
151. Purdy-Beale HA. Immunologic reactions with tobacco mosaic virus. J Exp Med 1929;49:919-935.
152. Qian X, Yoon B. Comparative analysis of protein interaction networks reveals that conserved pathways are susceptible to HIV-1 interception. BMC Bioinformatics 2011;12(Suppl 1):S19.
153. Rambaut A, Pybus O, Nelson M, et al. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008;453:615-619.
154. Reed W, Carroll J, Agramonte A, et al. Senate Documents 1901;66:156.
155. Relman D. 'Til death do us part': coming to terms with symbiotic relationships. Nat Rev Microbio 2008;10:721-724.
156. Reyes A, Haynes M, Hanson N, et al. Metagenomic analysis of viruses in the fecal microbiota of monozygotic twins and their mothers. Nature 2010;466:334-340.
157. Robins H, Krasnitz M, Barak H, et al. A Relative Entropy Algorithm for Genomic Fingerprinting Captures Host-Phage Similarities. J Bacteriol 2005;187:8370-8374.
158. Robins H, Krasnitz M, Levine A. The Computational Detection of Functional Nucleotide Sequence Motifs in the Coding Regions of Organisms. Exp Biol Med 2008;233:665-673.
159. Rous P. A Sarcoma of the Fowl Transmissible by an Agent Separable from the Tumor Cells. J Exp Med 1911;13:397-411.
160. Roux E. Sur les microbes dits invisible. Bull Inst Pasteur Paris 1903;1:49-56.
161. Rubinstein M, Rubinstein S, Familletti PC, et al. Human leukocyte interferon purified to homogeneity. Science 1978;202:1289-1290.
162. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989;63:3822-3828.
163. Sanford KK, Earle WR, Likely GD. The growth in vitro of single isolated tissue cells. J Natl Cancer Inst 1948;9:229-246.
164. Sarnow P, Ho YS, Williams J, et al. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54kd cellular protein in transformed cells. Cell 1982;28:387-394.
165. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-1136.
166. Schlesinger M. Die Bestimmung von Teilchengrïsse und Spezifischem gewicht des Bakteriophagen durch Zentrifugierversuche. Z Hyg Infektionskrankh 1932;114:161.
167. Schlesinger M. Zur Frage der chemischen Zusammensetzung des Bakteriophagen. Biochem Z 1934;273:306-311.
168. Schultz-Cherry S, Jones J. Influenza vaccines: the good, the bad, and the eggs. Adv Virus Res 2010;77:63-84.
169. Schwartz O, Albert M. Biology and pathogenesis of chikungunya virus. Nat Rev Microbio 2010;8:491-500.
170. Sharp P, Hahn B. The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci 2010;365:2487-2494.
171. Sinsheimer RL. A single-stranded DNA from bacteriophage phi X174. Brookhaven Symp Biol 1959;12:27-34.
172. Soll S, Stuart J, Neil D, et al. Identification of a receptor for an extinct virus. Proc Natl Acad Sci U S A 2010;107:19496-19501.
173. Stanley W. Isolation of a crystaline protein possessing the properties of tobacco-mosaic virus. Science 1935;81:644-645.
174. Stehelin D, Varmus HE, Bishop JM, et al. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 1976;260:170-173.
175. Straub O. Maedi-visna virus infection in sheep. History and present knowledge. Comp Immunol Microbiol Infect Dis 2004;27:1-5.
176. Streisinger G, Edgar RS, Denhardt GH. Chromosome Structure in Phage T4. I. Circularity of the Linkage Map. Proc Natl Acad Sci U S A 1964;51:775-779.
177. Suttle C. Marine viruses-major players in the global ecosystem. Nat Rev Microbiol 2007;5:801-812.
178. Suttle CA. Viruses in the sea. Nature 2005;437:356-361.
179. Szpara M, Kobiler O, Enquist L. A Common Neuronal Response to Alphaherpesvirus Infection. J Neuroimmune Pharmacol 2010;5:418-427.
180. Takahashi WN, Rawlins RE. Method for determining shape fo colloidal particles: Applications in study of tobacco mosaic virus. Proc Natl Acad Sci U S A 1932;30:155-157.
181. Takatsuki K, Uchuyama T, Ueshima Y. Adult T-cell leukemia: Proposal as a new disease and cytogenetic, phenotypic and function studies of leukemic cells. Gann Monogr Cancer Res 1982;28:13-22.
182. Tang J, Shetty N, Lam T, et al. Emerging, novel, and known influenza virus infections in humans. Infect Dis Clin North Am 2010;24:603-617.
183. Tang P, Chiu C. Metagenomics for the discovery of novel human viruses. Future Microbiol 2010;5:177-189.
184. Taubenberger J, Kash J. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 2010;7:440-451.
185. Temin HM, Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970;226:1211-1213.
186. Thomas CA Jr. The arrangement of information in DNA molecules. J Gen Physiol 1966;49:143-169.
187. Tulsiani S, Graham G, Moore P, et al. Emerging tropical diseases in Australia. Part 5, Hendra virus. Ann Trop Med Parasitol 2011;105:1-11.
188. Twort FW. The bacteriophage: The breaking down of bacteria by associated filter-passing lysins. Br Med J 1922;2:293.
189. Twort FW. The discovery of the bacteriophage. Sci News 1949;14:33.
190. Twort FW. An investigation on the nature of the ultramicroscopic viruses. Lancet 1915;189:1241-1243.
191. Uchiyama T, Yodoi J, Sagawa K, et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-492.
192. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-1351.
193. Vinson CG, Petre AW. Mosaic disease of tobacco. Botan Gaz 1929;87:14-38.
194. Wang D, Urisman A, Liu YT, et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol 2003;1:E2.
195. Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 1953;171:737-738.
196. Weil PA, Luse DS, Segall J, et al. Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNA. Cell 1979;18:469-484.
197. Weil R, Vinograd J. The Cyclic Helix and Cyclic Coil Forms of Polyoma Viral DNA. Proc Natl Acad Sci U S A 1963;50:730-738.
198. Weiss R, Teich N, Varmus H, et al. RNA Tumor Viruses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1982.
199. Weitzman M, Lilley C, Chaurushiya M. Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol 2010;13:61-81.
200. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-79.
201. Whyte P, Buchkovich KJ, Horowitz JM, et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988;334:124-129.
202. Willner D, Furlan M, Haynes M, et al. Metagenomic analysis of respiratory tract DNA viral communities in Cystic Fibrosis and Non-Cystic Fibrosis individuals. PLoS One 2009;4:1-12.
203. Willner D, Thurber R, Rohwer F. Metagenomic signatures of 86 microbial and viral metagenomes. Env Micro 2009;16:75-84.
204. Wolbach SB. The Filterable Viruses, a Summary. J Med Res 1912;27:1-25.
205. Woodruff AM, Goodpasture EW. The susceptibility of the chorio-allantoic membrane of chick embryos to infection with the fowl-pox virus. Am J Pathol 1931;7:209-222.5.
206. Worcel A, Burgi E. On the structure of the folded chromosome of Escherichia coli. J Mol Biol 1972;71:127-147.
207. Wyatt GR, Cohen SS. The bases of the nucleic acids of some bacterial and animal viruses: the occurrence of 5-hydroxymethylcytosine. Biochem J 1953;55:774-782.
208. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 1982;79:2031-2035.
209. Zhao R, Gish K, Murphy M, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2000;14:981-993.
210. Zinder ND, Lederberg J. Genetic exchange in Salmonella. J Bacteriol 1952;64:679-699.
211. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974;248:701-702.
212. zur Hausen H. Viruses in human cancers. Science 1991;254:1167-1173.